ArticleDiscover oncology2026

A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery.

Yiwei Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.